Autologous Cell Therapy Market to Expand at 18.1% CAGR during the Forecast Period, Reveals latest TMR Study

Transparency Market Research has released its latest report on the global 𝐚𝐮𝐭𝐨𝐥𝐨𝐠𝐨𝐮𝐬 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐦𝐚𝐫𝐤𝐞𝐭, covering the historical period from 2017 to 2018 and forecasting trends for 2019 to 2027. The report indicates that the rising prevalence of autoimmune disorders, cancer, and blood-related disorders is expected to be a significant driver for the global autologous cell therapy market during the forecast period.

As per the report, the global autologous cell therapy market was valued at US$ 7.5 billion in 2018. Furthermore, it is anticipated to witness a robust compound annual growth rate (CAGR) of 18.1% to reach US$ 34.7 Bn from 2019 to 2027.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

The global autologous cell therapy market is experiencing rapid expansion, fueled by a surge in the prevalence of autoimmune diseases, cancer, and orthopedic disorders. The American Autoimmune Related Diseases Association (AARDA) reports that approximately 50 million individuals in the United States are afflicted with autoimmune diseases, a number projected to escalate in the future. Moreover, the increasing utilization of autologous cell therapy in treating various conditions including neurological, orthopedic, oncological, and a diverse array of autoimmune diseases is poised to propel market growth during the forecasted period.

The American Cancer Society discloses that in 2019 alone, there were 1,762,450 newly diagnosed cancer cases and 606,880 cancer-related deaths in the United States. Additionally, The Parkinson's Foundation reveals that presently, over 10 million people worldwide are grappling with Parkinson's disease (PD).

These statistics underscore the pressing need for advanced therapeutic solutions like autologous cell therapy, which holds promise in addressing a spectrum of debilitating diseases. As research continues to unravel the potential applications of this innovative treatment modality, the autologous cell therapy market is expected to witness sustained growth in the coming years.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Pharmicell Co., Inc.,Castle Creek Biosciences, Inc.,Vericel Corporation,Lineage Cell Therapeutics, Inc.,BrainStorm Cell Therapeutics,Caladrius Biosciences, Inc.,Opexa Therapeutics, Inc.,Regeneus Ltd.,Takeda Pharmaceutical Company Limited.,Sangamo Therapeutics,U.S. Stem Cell, Inc.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Source

Bone Marrow (Blood)
Epidermis
Others

Application

Neurology
Orthopedic
Cancer
Wound Healing (including Skin)
Cardiovascular Disorders
Autoimmune Disorders
Others

End-user

Hospitals
Ambulatory Centers
Research Centers

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Key drivers include the rising prevalence of chronic diseases, growing geriatric population, and surging investments in biotechnology and regenerative medicine. However, regulatory complexities, high treatment costs, and ethical concerns pose significant challenges to market growth.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Notable trends include the adoption of advanced cell isolation and processing technologies, increasing collaborations between pharmaceutical companies and research institutions, and the emergence of novel therapeutic applications.

𝐒𝐭𝐫𝐨𝐧𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐏𝐢𝐩𝐞𝐥𝐢𝐧𝐞 𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐁𝐨𝐨𝐬𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡

Prominent manufacturers are directing their efforts towards research and development to introduce novel autologous cell therapy products. Presently, TESSA Therapeutics stands out with its innovative autologous cell therapy product, TT12, which is currently in Phase 1 clinical trials for the treatment of HPV-Associated Cancers. A robust product pipeline such as this plays a pivotal role in propelling the market's growth trajectory.

The anticipated growth of this market is further bolstered by increasing government support and funding initiatives. Notably, the National Institute of Health (NIH) allocated approximately US$ 2 billion for stem cell research in the United States in 2019. Such substantial financial backing from governmental bodies is expected to significantly fuel the expansion of the autologous cell therapy market in the forecasted period.

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=715<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In October 2019, American Gene Technologies (AGT) submitted Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for AGT103-T in the treatment of HIV patients.

In August 2018, KOLIGO THERAPEUTICS, INC. launched KYSLECEL, which is autologous cell therapy product for treatment of chronic or acute recurrent pancreatitis.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Evaluation of market dynamics, including drivers, challenges, and trends.
Analysis of market segmentation by service type, sourcing type, application, industry vertical, and region.
Assessment of regional market landscapes and emerging opportunities.
Examination of regulatory frameworks and their impact on market dynamics.
Profiling of key market players and competitive landscape analysis.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐏𝐨𝐭𝐚𝐬𝐬𝐢𝐮𝐦-𝐈𝐨𝐧 𝐁𝐚𝐭𝐭𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2022/12/06/2568579/0/en/Potassium-Ion-Battery-Market-to-Reach-US-4-1-Bn-by-2031-TMR-Study.html

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐲𝐧𝐚𝐦𝐨𝐦𝐞𝐭𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2022/12/07/2569655/0/en/Medical-Dynamometer-Market-to-Reach-US-984-6-Mn-by-the-end-of-2026-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com  
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.